RPID
HealthcareRapid Micro Biosystems, Inc.
$3.06
$-0.08 (-2.55%)
Jan 5, 2026
Price History (1Y)
Analysis
Rapid Micro Biosystems, Inc. is a healthcare company operating in the medical devices industry. The company has a market capitalization of $135.63 million and generates revenue of approximately $30.52 million (TTM), employing 163 people. The company's financial health is concerning, with negative profitability margins (-145.1% for both operating and profit margins) and significant net income losses ($-44,292,000 TTM). Return on Equity (ROE) and Return on Assets (ROA) are also negative at -68.8% and -29.8%, respectively. The balance sheet shows a relatively low debt-to-equity ratio of 11.91, but the company has a significant amount of cash ($41.95 million) compared to its debt ($5.28 million), resulting in a current ratio of 4.23. Rapid Micro Biosystems, Inc.'s valuation is characterized by a negative forward P/E ratio (-3.57) and an EV/EBITDA ratio of -2.41. The company's revenue growth rate (YoY) is 3.1%, but its earnings growth rate is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $135.63M
- P/E Ratio
- N/A
- 52-Week High
- $4.50
- 52-Week Low
- $0.98
- Avg Volume
- 116.78K
- Beta
- 1.37
Company Info
- Industry
- Medical Devices
- Exchange
- NCM
- Country
- United States
- Employees
- 163